Gerry Castillo
Direttore Tecnico/Scientifico/R&S presso PharmaIN Corp.
Profilo
Gerry Castillo is currently the Director of Research & Intellectual Property at PharmaIN Corp.
Previously, he worked as the Biochemistry Director at ProteoTech, Inc. Castillo holds a doctorate degree from the University of Toronto, an undergraduate degree from the University of Saskatchewan, and a graduate degree from the University of Windsor.
Posizioni attive di Gerry Castillo
| Società | Posizione | Inizio |
|---|---|---|
PharmaIN Corp.
 PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Direttore Tecnico/Scientifico/R&S | - |
Precedenti posizioni note di Gerry Castillo
| Società | Posizione | Fine |
|---|---|---|
ProteoTech, Inc.
 ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | Corporate Officer/Principal | - |
Formazione di Gerry Castillo
| University of Toronto | Doctorate Degree |
| University of Saskatchewan | Undergraduate Degree |
| University of Windsor | Graduate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 2 |
|---|---|
PharmaIN Corp.
PharmaIN Corp. Pharmaceuticals: MajorHealth Technology PharmaIN Corp. develops affinity-based drug delivery solutions for biotech and pharmaceutical applications. It develops drug therapies using its proprietary, novel drug delivery platform called Protected Graft Co-polymer. The company was founded by Elijah M. Bolotin in 2000 and is headquartered in Bothell, WA. | Health Technology |
ProteoTech, Inc.
ProteoTech, Inc. Medical/Nursing ServicesHealth Services ProteoTech, Inc. operates as a private drug development company. It focuses on targeting amyloid diseases. The firm is utilizing its amyloid and proteoglycan expertise in an effort to transform the lives of victims of Alzheimer's disease, Parkinson's disease, type 2 diabetes, and systemic amyloidosis. The company was founded in 1996 and is headquartered in Seattle, WA. | Health Services |
- Borsa valori
- Insiders
- Gerry Castillo
